Image For Activity Cover
SSO & ESSO HPB Joint Virtual Tumor Board: Multimodality Management of Pancreatic Cancer(OnDemand) 2023
Activity Overview

This event was held on Friday, August 18th at 12:00PM (CST).

SSO Hepato-Pancreato-Biliary Disease Site Work Group is pleased to collaborate with the European Society of Surgical Oncology to discuss Multimodality Management of Pancreatic Cancer.

After this virtual tumor board, the participants will be able to: 

  • To understand similarities and differences in the definitions of resectable and borderline resectable pancreatic adenocarcinoma between Europe and North America.
  • To discuss neoadjvant and adjuvant therapy regimens as well as principles of surgical resection from a North American and European perspective
  • To discuss the management of borderline resectable disease including neoadjuvant regimens and vascular resections
  • To discuss the management of oligometastatic disease

Moderators - SSO

  • Alexander A. Parikh, MD, MPH, FACS, FSSO - UT Health San Antonio Mays-MD Anderson Cancer Center
  • Julie Hallet, MD, MSc, FRCSC, FSSO - University of Toronto, Sunnybrook Health Sciences Centre, Canda
  • Hassan Malik, MD -Liverpool University Hospitals NHS Foundation Trust
  • Stefan Staettner, MD, FRCS, FEBS - Johannes Kepler University, Voecklabuk, Austria


  • Kathleen Christians, MD, FACS - Medical College of Wisconsin
  • Patricio Polanco, MD, FACS, FSSO - University of Texas Southwestern, Medical Center, HPB DSWG Member
  • Jason Willis, MD - University of Texas MD Anderson Cancer Center
  • Stefan Fichtner-Feigl, MD - University Hospital Freiburg
  • Elena Rangelova, MD, PhD, FACS - Dept. of Upper Abdominal Surgery at Sahlgrenska University Hospital
  • Mairéad G McNamara, MB BCh BAO, BSc, B Med Sci, PhD, MRCP UK, PGCE - University of Manchester/The Christie NHS Foundation Trust


Availability: On-Demand
Cost: FREE
Credit Offered:
No Credit Offered
Powered By